A Scientific American forum on the controversial issue has some scientists crying foul, contending editors failed to delete misstatements. TRUST BUSTED: UC-Berkeley’s Sharon Russell says her faith in Scientific American has been shaken. Some biomedical researchers are responding with disappointment and concern to the February issue of Scientific American, contending that portions of the magazine's cover package, a forum on the benefits and ethics of animal research, were misleading and
A Scientific American forum on the controversial issue has some scientists crying foul, contending editors failed to delete misstatements. |
 TRUST BUSTED: UC-Berkeley’s Sharon Russell says her faith in Scientific American has been shaken. |
"ACCURATE": Neal Barnard, coauthor of the piece under the most scrutiny, contends the disagreements are matters of opinion. The piece that has caused most of the controversy among scientists is an article entitled "Animal Research ...
Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.
View this Issue
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
In this webinar, Linghua Wang and Jeremy Goecks will talk about technology that enables new approaches for a better understanding of tumors on a cellular, spatial, and environmental level.
Explore how researchers use organoids to understand tissue regeneration and develop novel therapies.
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces key accreditations in recognition of excellence in data security, AI innovation, and commitment to continuous improvement.
Partnership complements Sapient’s mass spectrometry-based proteomics services, extends multi-omics solutions, and will enable development of NULISAseq™ assays under regulated guidance
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 and 8, enabling determination of capsid titer, genome titer, and percentage of full capsids in purified or unpurified (crude lysate) samples.
Tailored nucleic acid extraction and amplification methods help scientists overcome the challenges of detecting Mycoplasma contamination in advanced therapy medicinal products.
